DICE Therapeutics (DICE) Stock Highlights

47.55 | +0%

2023-09-14 18:18:47

DICE Therapeutics Inc is a biopharmaceutical company leveraging proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. The company is initially focused on developing oral therapeutics against well-validated targets in immunology, with the goal of achieving comparable potency to systemic biologic counterparts, which have demonstrated the greatest therapeutic benefit to date in these disease areas.

Statistics

Range Today

47.55 47.55

Volume Today 0

Range 1 Year

15.08 47.9

Volume 1 Year 224.93M

Range 3 Year

12.64 47.9

Volume 3 Year 301.92M

Range 10 Year

12.64 47.9

Volume 10 Year 301.92M

Highlights

Market Capitalization 2.27B (mid)

Current Price 47.55

Performance

Latest 0%

1 Month +1.3%

3 Months +43.48%

6 Months +60.97%

1 Year +144.35%

3 Years +58.5%

5 Years +58.5%

10 Years +58.5%

Benchmarks

Market Capitalization

75 / 368

Gross Profits

203 / 278

Total Revenue

0 / 300

Total Rank

310 / 368

Free Cashflow

0 / 352

Performance 5 years

82 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.